Identification of surface-associated antigens for tumor diagnosis and therapy

US10036753B2 · kind B2 · utility

Assignee

• Ganymed Pharmaceuticals GmbH · DE

Inventors

• Ugur Sahin · Mainz, DE
• Ozlem Tureci · Homburg, DE
• Michael Koslowski · Mainz, DE
• Gerd Helftenbein · Mücke, DE
• Dirk Usener · Wiesbaden, DE
• Volker Schlüter · Schwanau, DE

Key dates

• Filing date: Jun 19, 2015
• Grant date: Jul 31, 2018
• Expiry date: Jun 19, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/158
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The invention relates to identifying tumor-associated genetic products and encoding nucleic acids thereof. A therapy and diagnosis of diseases in which the tumor-associated genetic products are aberrantly expressed, proteins, polypeptides and peptides which are expressed in association with tumor and the encoding nucleic acids for said proteins, polypeptides and peptides are also disclosed.